会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • AUTOMATIC ADJUSTING R-WAVE SYNCHRONIZATION ALGORITHM FOR ATRIAL CARDIOVERSION AND DEFIBRILLATION
    • 自动调整R波同步算法用于ATRIAL CARDIOVERSION和DEFIBRILLATION
    • WO2004098707A2
    • 2004-11-18
    • PCT/US2004/011748
    • 2004-04-16
    • MEDTRONIC, INC.MONGEON, Luc, R.MEHRA, Rahul
    • MONGEON, Luc, R.MEHRA, Rahul
    • A61N1/39
    • A61N1/3956A61N1/3987
    • An implantable medical device system and method are provided for synchronizing atrial cardioversion shocks to the ventricular rhythm using an adjustable atrial cardioversion/defibrillation ventricular refractory period. Upon determining a need for an atrial shock therapy, the method determines if the ventricular rate meets synchronization criteria based on an upper ventricular refractory period limit. If synchronization criteria are not met, the refractory period is automatically adjusted in stepwise decrements until the synchronization criteria are met, or until a lower refractory period limit is exceeded. If synchronization criteria are met, an atrial shock is synchronized to the next ventricular depolarization occurring outside the current refractory period. If the lower refractory period limit is exceeded, the atrial therapy is aborted.
    • 提供了一种植入式医疗装置系统和方法,用于使用可调节心房复律/除颤心室不应期使心房心律转复冲击与心室节律同步。 在确定需要心房休克治疗时,该方法确定心室率是否满足基于上心室不应期限的同步标准。 如果不符合同步标准,则可以逐步递减地自动调整不应期,直到达到同步标准,或直到超过较低的不应期限为止。 如果符合同步标准,心房休克与当前不应期以外发生的下一次心室去极化同步。 如果超过较低的不应期限,则中止心房治疗。
    • 5. 发明申请
    • AUTOMATIC OPTIMIZATION OF LOWR CARDIAC PACING RATE
    • 自动优化LOWR CARDIAC PACING RATE
    • WO2005105206A1
    • 2005-11-10
    • PCT/US2005/011853
    • 2005-04-08
    • MEDTRONIC, INC.ZIEGLER, Paul, D.HETTRICK, Douglas, A.MEHRA, Rahul
    • ZIEGLER, Paul, D.HETTRICK, Douglas, A.MEHRA, Rahul
    • A61N1/365
    • A61N1/365A61N1/3622
    • A method and device for determining an optimal lower rate (100) and adjusting the programmed lower pacing rate to the optimal rate (145) that includes monitoring a parameter (116) in response to therapy delivered (115) at a first rate during a first time period to generate first parameter data (120), and determining whether the therapy was delivered for a predetermined portion of the first time period (117). The parameter is monitored (116) in response to the therapy delivered (115) at a next rate (110) during a next time period (115) to generate next parameter data (116), and a determination is made as to whether the therapy was delivered for a predetermined portion of the next time period (117). A metric corresponding to the first parameter data is determined to generate a first parameter metric (135), and corresponding to the next parameter data to generate a next parameter metric (135) used for determining an optimal therapy delivery rate (140).
    • 一种用于确定最佳较低速率(100)并且将编程的较低起搏速率调整到最佳速率(145)的方法和装置,其包括响应于在第一次速率期间以第一速率传送(115)的治疗来监视参数(116) 产生第一参数数据(120)的时间段,以及确定治疗是否在第一时间段(117)的预定部分被递送。 响应于在下一个时间段(115)期间以下一个速率(110)递送的治疗(115)来响应参数(116)以产生下一个参数数据(116),并且确定治疗 被递送下一个时间段(117)的预定部分。 确定对应于第一参数数据的度量以产生第一参数度量(135),并且对应于下一参数数据以生成用于确定最佳治疗传送率(140)的下一个参数度量(135)。
    • 8. 发明申请
    • GENERATING FINGERPRINTED CONTENT DATA FOR PROVISION TO RECEIVERS
    • 产生用于接收者的指纹内容数据
    • WO2013120525A1
    • 2013-08-22
    • PCT/EP2012/052625
    • 2012-02-15
    • IRDETO BVPICKERING, AnthonyMEHRA, RahulHIETBRINK, Erik
    • PICKERING, AnthonyMEHRA, RahulHIETBRINK, Erik
    • H04N21/234H04N21/2343H04N21/8358H04N21/4405H04N21/2389G06T1/00H04N21/2347
    • H04L9/3247H04L2209/608H04N21/234345H04N21/23476H04N21/23892H04N21/23897H04N21/44055H04N21/8358
    • A method for generating, from initial content data, output content data for provision to one or more receivers, wherein the initial content data is encoded according to a coding scheme, wherein for a quantity of data encoded according to the coding scheme, the coding scheme provides a mechanism for including in the quantity of encoded data additional data such that a decoder for the coding scheme, upon decoding the quantity of encoded data, does not use the additional data to generate decoded data, the method comprising: selecting one or more portions of the initial content data; for each selected portion, generating a data construct that comprises a plurality of data structures, each data structure comprising data, including a version of the selected portion, that is encrypted using a corresponding encryption process different from each encryption process used to encrypt data in the other data structures, wherein the data construct is arranged such that using a decryption process that corresponds to the encryption process for one data structure on the encrypted data in each data structure in the data construct produces a quantity of data encoded according to the coding scheme that uses the mechanism so that a decoder for the coding scheme would not use any data structure in the data construct other than said one data structure; and using the generated data constructs in the initial content data instead of their corresponding selected portions to form the output content data.
    • 一种用于从初始内容数据生成用于提供给一个或多个接收器的输出内容数据的方法,其中,根据编码方案对初始内容数据进行编码,其中对于根据编码方案编码的数据量,编码方案 提供了一种用于在编码数据量中包括附加数据的机制,使得用于编码方案的解码器在解码编码数据量时不使用附加数据来生成解码数据,该方法包括:选择一个或多个部分 的初始内容数据; 对于每个所选择的部分,生成包括多个数据结构的数据结构,每个数据结构包括数据,包括所选部分的版本,其使用与用于加密数据的每个加密过程不同的对应加密过程进行加密 其他数据结构,其中数据结构被布置为使得对应于数据结构中的每个数据结构中的加密数据的一个数据结构的加密处理的解密处理产生根据编码方案编码的数据量, 使用该机制,使得用于编码方案的解码器不会在除所述一个数据结构之外的数据结构中使用任何数据结构; 以及在初始内容数据中使用生成的数据结构而不是其对应的所选部分来形成输出内容数据。
    • 9. 发明申请
    • CARDIAC PACING METHOD AND SYSTEM
    • CARDIAC PACING方法和系统
    • WO2003053513A2
    • 2003-07-03
    • PCT/US2002/041296
    • 2002-12-20
    • MEDTRONIC,INC.
    • HESS, Michael, F.WARMAN, Eduardo, N.BROWN, Mark, L.MEHRA, RahulSHETH, Nirav, V.RITSCHER, David
    • A61N1/00
    • A61N1/3622A61N1/3624
    • AbstractThe invention relates to the use of atrial pacing therapies to treat atrial tachycardia (AT). When an AT episode is detected, an implantable medical device applies an ATP therapy. If the AT episode persists, the ATP therapy may be automatically reapplied at a later time during the course of the same AT episode. In particular, previously used ATP therapies are reapplied when episodic conditions, such as cycle length or cycle regularity, change. Although a particular ATP therapy initially may be unsuccessful in terminating the AT, it may prove successful when the cycle length or regularity of the atrial rhythm changes. As the rhythm slows down, the AT may be more responsive to ATP therapies that were previously unsuccessful. As a result, potentially efficacious ATP therapies can be reapplied to terminate AT episodes, and reduce the number of episodes that require more aggressive termination by painful, atrial shocks.
    • 摘要本发明涉及心房起搏疗法治疗房性心动过速AT的应用。 当检测到AT发作时,可植入医疗装置应用ATP疗法。 如果AT发作持续存在,ATP疗法可能会在同一AT发作过程中的以后时间自动重新应用。 特别是,当诸如循环长度或循环规律性等情况时,先前使用的ATP疗法将被重新应用。 尽管特定的ATP疗法最初可能不能终止AT,但是当心房节律的周期长度或规律性发生变化时,可能会成功。 随着节奏减慢,AT可能对以前不成功的ATP疗法更有反应。 因此,可以重新应用潜在有效的ATP疗法来终止AT发作,并通过痛苦的心房休克减少需要更积极终止的发作次数。